LV12917B - Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation - Google Patents

Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation Download PDF

Info

Publication number
LV12917B
LV12917B LVP-02-137A LV020137A LV12917B LV 12917 B LV12917 B LV 12917B LV 020137 A LV020137 A LV 020137A LV 12917 B LV12917 B LV 12917B
Authority
LV
Latvia
Prior art keywords
weight
pharmaceutical composition
amount
controlled release
tramadol hydrochloride
Prior art date
Application number
LVP-02-137A
Other languages
English (en)
Latvian (lv)
Inventor
L Uboslav Razus
Helena Sedlarova
Ivan Varga
Ondrej Gattnar
Marian Zemanek
Original Assignee
Slovakofarma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma As filed Critical Slovakofarma As
Publication of LV12917B publication Critical patent/LV12917B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-02-137A 1999-12-28 2002-07-26 Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation LV12917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Publications (1)

Publication Number Publication Date
LV12917B true LV12917B (en) 2003-02-20

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-02-137A LV12917B (en) 1999-12-28 2002-07-26 Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation

Country Status (25)

Country Link
US (1) US20030175343A1 (fr)
EP (1) EP1255535B1 (fr)
JP (1) JP2003518486A (fr)
AT (1) ATE324103T1 (fr)
AU (1) AU2421601A (fr)
BG (1) BG65713B1 (fr)
CA (1) CA2397942C (fr)
CY (1) CY1106127T1 (fr)
CZ (1) CZ297394B6 (fr)
DE (1) DE60027601T2 (fr)
DK (1) DK1255535T3 (fr)
EA (1) EA006438B1 (fr)
EE (1) EE05231B1 (fr)
ES (1) ES2266018T3 (fr)
GE (1) GEP20053532B (fr)
HU (1) HUP0203842A3 (fr)
LT (1) LT5033B (fr)
LV (1) LV12917B (fr)
PL (1) PL208096B1 (fr)
PT (1) PT1255535E (fr)
SI (1) SI1255535T1 (fr)
SK (1) SK285128B6 (fr)
TW (1) TWI221419B (fr)
UA (1) UA76411C2 (fr)
WO (1) WO2001047497A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
CA2529604C (fr) * 2003-07-11 2012-05-08 Novartis Ag Compositions pharmaceutiques a dosage oral comprenant un agent d'apport sous forme micronisee
JP4926245B2 (ja) * 2006-06-09 2012-05-09 イノフォス インコーポレーテッド 透明飲料用のカルシウム強化物質
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
EP0654263B1 (fr) 1993-11-23 2002-01-23 Euro-Celtique S.A. Procédé pour la préparation d'une composition pharmaceutique à libération prolongée
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
PL357680A1 (en) 2004-07-26
EA200200720A1 (ru) 2003-02-27
JP2003518486A (ja) 2003-06-10
EA006438B1 (ru) 2005-12-29
CZ297394B6 (cs) 2006-12-13
CZ20022371A3 (cs) 2002-10-16
US20030175343A1 (en) 2003-09-18
BG65713B1 (bg) 2009-08-31
WO2001047497A2 (fr) 2001-07-05
EP1255535A2 (fr) 2002-11-13
TWI221419B (en) 2004-10-01
UA76411C2 (en) 2006-08-15
LT5033B (lt) 2003-07-25
BG106952A (en) 2003-03-31
EE05231B1 (et) 2009-12-15
SK285128B6 (sk) 2006-07-07
WO2001047497A3 (fr) 2002-09-12
CA2397942C (fr) 2008-07-15
CY1106127T1 (el) 2011-06-08
EP1255535B1 (fr) 2006-04-26
CA2397942A1 (fr) 2001-07-05
ES2266018T3 (es) 2007-03-01
EE200200368A (et) 2003-10-15
ATE324103T1 (de) 2006-05-15
LT2002078A (en) 2003-03-25
GEP20053532B (en) 2005-05-25
SI1255535T1 (sl) 2006-10-31
PT1255535E (pt) 2006-09-29
AU2421601A (en) 2001-07-09
DK1255535T3 (da) 2006-08-28
DE60027601D1 (de) 2006-06-01
HUP0203842A2 (hu) 2003-05-28
SK186899A3 (en) 2001-07-10
HUP0203842A3 (en) 2004-06-28
PL208096B1 (pl) 2011-03-31
DE60027601T2 (de) 2007-04-26

Similar Documents

Publication Publication Date Title
US6022533A (en) Tablets containing anion exchange resin
JPH05221854A (ja) 水溶性薬物を含有する制御的放出錠剤
EP3862318A1 (fr) Composition de particules de silice poreuse
JPH11124327A (ja) トラマドール又はその薬剤学上許容される塩の使用方法および鎮痛薬剤
CS247079B2 (en) Production method of the divisable tablet with retarded realising of its effective substance
IL177402A (en) Composition for oral administration of tamsulosin hydrochloride
CA2760043A1 (fr) Retigabine solide sous forme non cristalline
EP1255535B1 (fr) Composition pharmaceutique a liberation regulee contenant du chlorhydrate de tramadol et son procede de preparation
HRP20010650A2 (en) Controlled-release compositions of betahistine
US20100021393A1 (en) Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate
KR20100041780A (ko) 옥스카르바제핀을 포함하는 방출 제어형 고체 제제의 제조 방법 및 그에 의해 얻어질 수 있는 제제
JPH09169641A (ja) ロキソプロフェン製剤
WO2005013953A1 (fr) Comprimes de besylate de venlafaxine a liberation prolongee
SK279927B6 (sk) Orálne pevné farmaceutické prípravky obsahujúce ge
JP4636445B2 (ja) ソリフェナシンまたはその塩の安定な粒子状医薬組成物
JP2001151671A (ja) 突起付き粒子製剤
RU2289422C2 (ru) Фармацевтическая композиция на основе ноопепта
UA74991C2 (en) Oral therapeutic composition with controlled release of dihydrocodeine
SK15612000A3 (sk) Perorálne tablety s riadeným uvoľňovaním farmaceuticky akceptovateľných solí metoprololu a spôsob ich prípravy
SI21256A (sl) Stabilizacija profila sproščanja učinkovin iz formulacije
SK2262003A3 (sk) Perorálny liečivý prípravok s riadeným uvoľňovaním bupropion hydrochloridu a spôsob jeho prípravy
HU191102B (en) Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons